ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma

Gao, Mengqi; Lin, Yi*; Liu, Xing; Zhao, Zheng; Zhu, Zhiyuan; Zhang, Hongbo; Ban, Yunchao; Bie, Yanan; He, Xiaozheng; Sun, Xiang; Zhang, Shizhong*广东药学院; 南方医科大学; 中国医科大学; 1; y
Frontiers in Cell and Developmental Biology2021-4-30DOI: 10.3389/fcell.2021.654407
10被引4阅读
引用收藏
分享

摘要

Mutation of the telomerase reverse transcriptase (TERT) promoter has been demonstrated as an unfavorable prognostic marker in patients with isocitrate dehydrogenase wild-type (IDHwt) glioma. This study aimed to investigate the immune role of TERT promoter mutation status which could improve prognostic prediction in IDHwt. TERT mutation status, IDH mutation, and 1p-19q codeletion status data were obtained from 614 glioma cases from the Cancer Genome Atlas, and 325 cases from the Chinese Glioma Genome Atlas. The same information was obtained from 49 clinical glioma tissues. TERT mutation is preferentially present in glioblastoma and IDH-wt gliomas and is associated with poor prognosis. Moreover, TERT mutation was associated with infiltration of neutrophils and expression of neutrophil chemokines. which might partially contribute to the poor outcome in IDH-wt glioma. Furthermore, patients with IDH-wt glioma did not harbor increased peripheral neutrophils, implying that the infiltrated neutrophil in the tumor environment might due to cytokine chemotaxis. In this study, we hereby propose that TERT mutation might be a molecular driver of the dysfunctional immune microenvironment in IDH-wt glioma. TERT mutation may be a potential immune therapeutic target for optimizing treatment combinations and patient selection for glioma immunotherapy.

学科与关键词

关键词
TERT mutationgliomaIDH mutationneutrophilchemokinesRNA-seq
相关
加载中…
  • A Qualitative Signature to Identify TERT Promoter Mutant High-Risk Tumors in Low-Grade Gliomas
    Zheng, Weicheng; Zhang, Ruolan; Huang, Ziru; Li, Jianpeng; Wu, Haonan; Zhou, Yuwei; Zhu, Jinwei; Wang, Xianlong*Frontiers in Molecular Biosciences, 2022, 9: 806727.被引 1
  • The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma
    Yu, Jiayin; Lai, Mingyao; Zhou, Zhaoming*; Zhou, Jiangfen; Hu, Qingjun; Li, Juan; Li, Hainan; Chen, Longhua; Wen, Lei; Zhou, Meijuan*; Cai, Linbo*Journal of Neuroimmunology, 2023, 376: 578034.被引 1
  • The immune regulation of BCL3 in glloblastoma with mutated IDH1
    Fan, Shibing; Wu, Na; Chang, Shichuan; Chen, Long; Sun, Xiaochuan*Aging-US, 2022, 14(9): 3856-3873.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2021-04-30
卷期
第 9 卷
页码
654407
DOI
10.3389/fcell.2021.654407
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81671240]; Liaoning Science and Technology Plan Project [2014021068]

作者

  • G

    Gao, Mengqi (第一作者)

    southern med univ

  • L

    Lin, Yi (通讯)

    1 · china med univ

查看全部 11 位作者收起作者
  • L

    Liu, Xing

  • Z

    Zhao, Zheng

    capital med univ

  • Z

    Zhu, Zhiyuan

    univ hong kong · southern med univ

  • Z

    Zhang, Hongbo

    southern med univ

  • B

    Ban, Yunchao

    1 · china med univ

  • B

    Bie, Yanan

    guangdong pharmaceut univ

  • H

    He, Xiaozheng

    southern med univ

  • S

    Sun, Xiang

    southern med univ

  • Z

    Zhang, Shizhong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417